The Frequency, Antifungal Susceptibility and Enzymatic Profiles of Candida Species Isolated from Neutropenic Patients | Zendy

Maral Gharaghani | Zendy; Ali RezaeiMatehkolaei | Zendy; Ali Zarei Mahmoudabadi | Zendy; Bijan Keikhaei | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The Frequency, Antifungal Susceptibility and Enzymatic Profiles of Candida Species Isolated from Neutropenic Patients

Author(s) -

Maral Gharaghani,

Ali RezaeiMatehkolaei,

Ali Zarei Mahmoudabadi,

Bijan Keikhaei

Publication year - 2016

Publication title -

jundishapur journal of microbiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.281

H-Index - 29

eISSN - 2008-4161

pISSN - 2008-3645

DOI - 10.5812/jjm.41446

Subject(s) - fluconazole , microbiology and biotechnology , candida krusei , neutropenia , caspofungin , amphotericin b , candida albicans , corpus albicans , biology , candida glabrata , medicine , chemotherapy , antifungal

We found a marked increase in the incidence of non- species (48.2%) among neutropenic patients. Only a few strains failed to produce extracellular enzymes. Finally, in addition to fluconazole, caspofungin can be considered as the first line treatment against a species among neutropenic patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research